Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Enrique José
Andreu Oltra
Profesional Investigador
Publicaciones en las que colabora con Enrique José Andreu Oltra (42)
2024
-
A Bioreactor for Celullarised Membrane Culture and Delivery under Sterile Conditions
Bioengineering, Vol. 11, Núm. 8
2023
-
Enhanced bioprocess control to advance the manufacture of mesenchymal stromal cell-derived extracellular vesicles in stirred-tank bioreactors
Biotechnology and Bioengineering, Vol. 120, Núm. 9, pp. 2725-2741
2022
-
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
Frontiers in Immunology, Vol. 13
2021
2020
-
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
EClinicalMedicine, Vol. 25
-
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)
Frontiers in Immunology
-
Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis
Journal of Translational Medicine, Vol. 18, Núm. 1
2019
-
Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
Frontiers in Immunology, Vol. 10, Núm. JUN
2018
2017
-
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Journal of Translational Medicine, Vol. 15, Núm. 1
-
Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation
Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 745-754
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
2016
-
Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue
Stem Cell Research, Vol. 16, Núm. 1, pp. 20-23
-
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: Multicenter randomized controlled clinical trial (phase I/II)
Journal of Translational Medicine, Vol. 14, Núm. 1
2015
2014
-
Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy
International Journal of Ophthalmology, Vol. 7, Núm. 6, pp. 988-995
-
Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis
PLoS ONE, Vol. 9, Núm. 12
-
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 10, pp. 1580-1585
2013
-
Culture of human bone marrow-derived mesenchymal stem cells on of poly(l-lactic acid) scaffolds: Potential application for the tissue engineering of cartilage
Knee Surgery, Sports Traumatology, Arthroscopy, Vol. 21, Núm. 8, pp. 1737-1750
2011
-
Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo
Dermatology Research and Practice, Vol. 2011